The above chart presents the market trend analysis for shandong kehui pharmceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 2 transactions, with a transaction quantity of 2 and a transaction weight of 0.22.
Product description
XAMINED THE CONSIGNMENT AND FOUND PHARMACEUTICAL RAW MATERIAL AS PER LABEL PASTED ON THE CTN DETAIL IS AS UNDER:- 1. LASMIDITAN HEMISUCCINATE BATCH NO .las20260401 MFG DATE. 02/04/2026 EXP DATE 01/04/2028 ORIGIN china QUANTITY =2 KG NET INVOICE DULY ATTASTED BY ADC DRAP PESHAWAR CLEARANCE CERTIFICATE NO.PIC-D/R/00704//42026 DATED: 29/04/2026 SCNNED ATTACHED FORM 3 5 7 AND CERTIFICATE OF ANALYSIS ARE SCANNED ATTACHED.
Expand
5ajanta pharma ltd.
united statesbuyer,they trade on 2022-11-22
16.25%
>
+View All
Products
Total 17
ProductsTransactionsPerDetail
bromfenac sodium 440%>
nepafenac 330%>
cro 330%>
pharmaceutical 220%>
bat 220%>
+View All
Hscode rank
Total 6
HSCode NameTransactionsPerDetail
HS 29163900550%>
HS 29241990330%>
HS 29339990220%>
Trading Area
Total 3
AreaTransactionsPerDetail
pakistan850.00%>
bangladesh743.75%>
india16.25%>
shandong kehui pharmceutical co.ltd. is china Supplier,
and primarily engages in the import and export business of products such as bromfenac sodium,nepafenac,cro.
According to the 52wmb.com global trade database, as of 2026-05-04, the company has completed 16 international trades,
with its main trading regions covering pakistan,bangladesh,india etc.
The core products include HS29163900,HS29241990,HS29339990 etc,
and its main trading partners are aristopharma ltd. change from,helix pharm pvt ltd.,s.j.& g.fazul ellahe pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shandong kehui pharmceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.